GU CONNECT has summarised the highlights from ESMO 2018 for you.
GU oncology by Dr. Fabio Schutz, Beneficencia Portuguesa de Sao Paulo, Brazil
Dr Fabio Schutz graduated from Parana Federal University and did his internal medicine residency at Hospital de Clinicas in Curitiba - PR, Brazil. Then, he moved to São Paulo - SP for his medical oncology clinical fellowship at Hospital Sirio Libanes. After finishing his medical oncology fellowship, he worked for a couple of years as an assistant medical oncologist in the same hospital. From 2009 to 2011, he worked as a research fellow in genitourinary (GU) oncology in the Lank Center for GU Oncology at the Dana-Farber Cancer Institute - Harvard Medical School in Boston - MA, USA. He developed several original research projects and authored many manuscripts in high-impact journals. Since mid-2011, he is working as a medical oncologist of the BP - Beneficencia Portuguesa de Sao Paulo in Sao Paulo - SP, Brazil. He is most interested and is currently conducting clinical trials in GU cancers.
Dr Fabio Schutz has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Astellas, Bayer, BMS, Janssen and Ipsen
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Share this programme
Brought to you by
GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.
Meet the experts
Other programmes of interest
Podcast
Hemostasis and bleeding disorders Oncology
Σειρά podcast για τη διαχείριση της θρόμβωσης
Αναλύσεις από καταξιωμένους ειδικούς ιατρούς. Πλοηγηθείτε στις καρτέλες για να επιλέξετε ένα επεισόδιο podcast
Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga-
Downloadable
Resources -
27 MIN
-
Feb 2025
Conference update
Oncology
ESMO Virtual Plenary: Final OS results from the phase III TROPION-Breast01 trial
How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?
Experts
Prof. François-Clément Bidard, Dr Barbara Pistilli-
5 MIN
-
Feb 2025
Podcast
Oncology Obstetrics and Gynecology
Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions
Understanding the role of molecular subtypes in guiding treatment selection
Experts
Prof. Xavier Matias-Guiu, Dr Jurjees HasanEndorsed by
-
Downloadable
Resources -
11 MIN
-
Feb 2025
Podcast
Hemostasis and bleeding disorders Oncology
Postępowanie w przypadku zakrzepicy – seria podcastów
Uznani eksperci dzielą się swoimi spostrzeżeniami. Kliknij na odpowiednią zakładkę, aby wybrać odcinek podcastu.
Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga-
Downloadable
Resources -
27 MIN
-
Feb 2025
Conference update
Oncology
Highlights from ASCO GI 2025
Expert insights on BRAF-mutated colorectal cancer
Experts
Dr Elena ÉlezEndorsed by
-
Downloadable
Resources -
5 MIN
-
Feb 2025
Podcast
Episode
4
of 4
Oncology
HCC podcast series part 4: Intermediate HCC – the evolving role of IO
Integrating multimodal approaches with multidisciplinary care
Experts
Dr Edward Kim, Dr Nina Sanford, Dr Mark Yarchoan, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
27 MIN
-
Jan 2025
